These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 500575)

  • 1. Nylidrin HCL in the treatment of symptoms of the aged: a double-blind placebo controlled study.
    Goldstein SE; Birnbom F
    J Clin Psychiatry; 1979 Dec; 40(12):520-4. PubMed ID: 500575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
    Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
    Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled study of the effect of dihydroergocristine on organic brain psychosyndrome].
    Aranda B; Dumoulin P; Groothold G
    Arzneimittelforschung; 1992 Nov; 42(11A):1406-9. PubMed ID: 1492863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dihydroergocristine in organic brain psychosyndrome. Multicenter placebo-controlled clinical double-blind study in 240 patients].
    Lazzaroni M; Cattalini C; Massetto N; Poli A
    Arzneimittelforschung; 1992 Nov; 42(11A):1410-3. PubMed ID: 1492864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study.
    Görtelmeyer R; Erbler H
    Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of disorders of cerebral performance in the aged in ambulatory care using bencyclane. Results of a controlled double-blind phase III study versus placebo].
    Garweg G; Herrmann WM; Kern U
    Z Gerontol; 1987; 20(1):56-62. PubMed ID: 3554804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial.
    Ditzler K
    Arzneimittelforschung; 1991 Aug; 41(8):773-80. PubMed ID: 1781796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
    Schöne W; Ludwig M
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the effects of pyritinol on functional deficits of patients with organic mental disorders.
    Herrmann WM; Kern U; Röhmel J
    Pharmacopsychiatry; 1986 Sep; 19(5):378-85. PubMed ID: 3534901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.
    Darbinyan V; Aslanyan G; Amroyan E; Gabrielyan E; Malmström C; Panossian A
    Nord J Psychiatry; 2007; 61(5):343-8. PubMed ID: 17990195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dihydroergocristine in the treatment of organic brain psychosyndrome. Dose-finding study against placebo].
    Milvio C
    Arzneimittelforschung; 1992 Nov; 42(11A):1399-402. PubMed ID: 1492861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ginkgolip, a new geriatric drug. Results of a double-blind study].
    Schenker H
    Aktuelle Gerontol; 1983 May; 13(3):104-7. PubMed ID: 6135355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
    Baro F; Malfroid M; Waegemans T; Cox JP
    Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol.
    Lovett WC; Stokes DK; Taylor LB; Young ML; Free SM; Phelan DG
    J Clin Psychiatry; 1987 Jun; 48(6):234-6. PubMed ID: 3294815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.
    Feighner JP; Merideth CH; Claghorn JL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):47-51. PubMed ID: 6370974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.